Studie Frauenkrankheiten (Gynäkologie)

Acute Inflammation — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Acute Inflammation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acute Inflammation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe... mehr

Ovarian Disease — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Ovarian Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involv... mehr

Premenstrual Syndrome — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ... mehr

Female Hypoactive Sexual Desire Disorder — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with latest updates, and special features ... mehr

Cervical Dysplasia — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Cervical Dysplasia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe... mehr

EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022


Summary


The urogenital tract, specifically the vagina, urethra, bladder, trigone of the bladder, and pelvic floor muscles, contains estrogen receptors. Estrogen is needed for the health of these tissues and structures, a lack of which causes them to undergo atrophy (Castelo-Branco and Rostro, 2007; Nappi and Kokot-Kierepa, 20... mehr

Female Sexual Dysfunction — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Female Sexual Dysfunction - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It a... mehr

Menopausal Disorders — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

Menopausal Hot Flashes — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also revie... mehr

Uterine Fibroids — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Uterine Fibroids - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Uterine Fibroids, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Vaginal Atrophy (Atrophic Vaginitis) — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with latest updates, and special features on late-stag... mehr

Contraceptives — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Contraceptives - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Contraceptives, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ... mehr

Dysmenorrhea — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the... mehr

Endometriosis — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Endometriosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Endometriosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ... mehr

Women Infertility — Pipeline Review, H1 2013


Summary


Global Markets Direct’s, 'Women Infertility - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Women Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ... mehr

Premature Labor (Tocolysis) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Premature Labor (Tocolysis) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Premature Labor (Tocolysis), complete with latest updates, and special features on late-stage and discontinued projects... mehr

Vasomotor Symptoms of Menopause — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with latest updates, and special features on late-stage and disconti... mehr

Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen


Summary


GBI Research, a leading business intelligence provider, has released its latest research, 'Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen”, which provides insights into the global contr... mehr

Premature Ovarian Failure — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Premature Ovarian Failure - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Premature Ovarian Failure, complete with latest updates, and special features on late-stage and discontinued projects. It a... mehr

Premenstrual Syndrome — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ... mehr

Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy


Summary


GBI Research, a leading business intelligence provider, has released its latest research, 'Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile... mehr

Endometriosis Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Endometriosis Global Clinical Trials Review, H2, 2012' provides data on the Endometriosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endometriosis. It includes an overview of the trial numbers and their recruitment status as per the site ... mehr

Primary Dysmenorrhea — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Primary Dysmenorrhea - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Primary Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

Cervical Dysplasia — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Cervical Dysplasia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key playe... mehr

Female Sexual Dysfunction — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Female Sexual Dysfunction - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It a... mehr

Menopausal Disorders — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

Menopausal Disorders — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key... mehr

Menopausal Hot Flashes — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also revie... mehr

Other Gynecological Disorders — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Other Gynecological Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Gynecological Disorders, complete with latest updates, and special features on late-stage and discontinued pr... mehr

Pregnancy — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Pregnancy - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pregnancy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeu... mehr

Uterine Fibroids — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Uterine Fibroids - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Uterine Fibroids, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Vaginal Atrophy (Atrophic Vaginitis) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy (Atrophic Vaginitis), complete with latest updates, and special features on late-stag... mehr

Abortion — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Abortion - Pipeline Review, H2 2012', provides an overview of the Abortion therapeutic pipeline. This report provides information on the therapeutic development for Abortion, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic devel... mehr

Contraceptives — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Contraceptives - Pipeline Review, H2 2012', provides an overview of the Contraceptives therapeutic pipeline. This report provides information on the therapeutic development for Contraceptives, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ... mehr

Dysmenorrhea — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, H2 2012', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the t... mehr

Endometriosis — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Endometriosis - Pipeline Review, H2 2012', provides an overview of the Endometriosis therapeutic pipeline. This report provides information on the therapeutic development for Endometriosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in t... mehr

Female Infertility — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Female Infertility - Pipeline Review, H2 2012', provides an overview of the Female Infertility therapeutic pipeline. This report provides information on the therapeutic development for Female Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Labor And Delivery — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Labor And Delivery - Pipeline Review, H2 2012', provides an overview of the Labor And Delivery therapeutic pipeline. This report provides information on the therapeutic development for Labor And Delivery, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Ovarian Disease — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Ovarian Disease - Pipeline Review, H2 2012', provides an overview of the Ovarian Disease therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invol... mehr

Polycystic Ovarian Syndrome — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Polycystic Ovarian Syndrome - Pipeline Review, H2 2012', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and disconti... mehr

Premenstrual Dysphoric Disorder (PMDD) — Pipeline Review, H2 2012


Summary


Global Markets Direct’s, 'Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H2 2012', provides an overview of the Premenstrual Dysphoric Disorder (PMDD) therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Dysphoric Disorder (PMDD), complete with latest updates, and... mehr

Cervical Dysplasia Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Cervical Dysplasia Global Clinical Trials Review, H2, 2012' provides data on the Cervical Dysplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Dysplasia. It includes an overview of the trial numbers and their recruitment sta... mehr

Uterine Fibroids Global Clinical Trials Review, H2, 2012


Summary


GlobalData's clinical trial report, 'Uterine Fibroids Global Clinical Trials Review, H2, 2012' provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment status as p... mehr

Pregnancy Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Pregnancy Global Clinical Trials Review, H1, 2012' provides data on the Pregnancy/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pregnancy/Impaired Glucose Tolerance. It includes an overview of the trial numbers and thei... mehr

Premature Labor (Tocolysis) — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Premature Labor (Tocolysis) - Pipeline Review, H1 2012', provides an overview of the Premature Labor (Tocolysis) therapeutic pipeline. This report provides information on the therapeutic development for Premature Labor (Tocolysis), complete with latest updates, and special features on late-stage and disconti... mehr

Premenstrual Syndrome — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, H1 2012', provides an overview of the Premenstrual Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also r... mehr

Post Menopausal Osteoporosis — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Post Menopausal Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Post Menopausal Osteoporosis therapeutic pipeline. This report provides information on the therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and disc... mehr

Primary Dysmenorrhea — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Primary Dysmenorrhea - Pipeline Review, H1 2012', provides an overview of the Primary Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Primary Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also revie... mehr

Cervical Dysplasia — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Cervical Dysplasia - Pipeline Review, H1 2012', provides an overview of the Cervical Dysplasia therapeutic pipeline. This report provides information on the therapeutic development for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Female Sexual Dysfunction — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Female Sexual Dysfunction - Pipeline Review, H1 2012', provides an overview of the Female Sexual Dysfunction therapeutic pipeline. This report provides information on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued pro... mehr

Menopausal Disorders — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H1 2012', provides an overview of the Menopausal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also revie... mehr

Menopausal Hot Flashes — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H1 2012', provides an overview of the Menopausal Hot Flashes therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It al... mehr

Uterine Leiomyoma (Uterine Fibroids) — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2012', provides an overview of the Uterine Leiomyoma (Uterine Fibroids) therapeutic pipeline. This report provides information on the therapeutic development for Uterine Leiomyoma (Uterine Fibroids), complete with latest updates, and special... mehr

Vaginal Atrophy — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Vaginal Atrophy - Pipeline Review, H1 2012', provides an overview of the Vaginal Atrophy therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invol... mehr

Dysmenorrhea — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, H1 2012', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the t... mehr

Endometriosis — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Endometriosis - Pipeline Review, H1 2012', provides an overview of the Endometriosis therapeutic pipeline. This report provides information on the therapeutic development for Endometriosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in t... mehr

Female Infertility — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Female Infertility - Pipeline Review, H1 2012', provides an overview of the Female Infertility therapeutic pipeline. This report provides information on the therapeutic development for Female Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p... mehr

Polycystic Ovarian Syndrome — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Polycystic Ovarian Syndrome - Pipeline Review, H1 2012', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and disconti... mehr

Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, 'Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012' provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial numbe... mehr

Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Postmenopausal Vaginal Atrophy Therapeutics market. ... mehr

TechNavio’s analysts forecast the Digital Mammography market in the US to grow at a CAGR of 6.4 percent over the period 2010—2014. One of the key factors contributing to this market growth is the recent advancement in 3D Tomosynthesis. The Digital Mammography market in the US has also been witnessing adoption to dual-energy digital mammography. However, growth of magnetic resonance imaging (MRI) could pose a challenge to the gro... mehr

Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Osteoporosis Market

Summary

GBI Research, a leading business intelligence provider, has released its latest research 'Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Oste... mehr

Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Fibromyalgia Therapeutics market. The report identifies the key trends shaping and driving the globa... mehr

Cervical Dysplasia Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Cervical Dysplasia Global Clinical Trials Review, H2, 2011' provides data on the Cervical Dysplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cervical Dysplasia. It includes an overview of the trial numbers and their recruitment status as per t... mehr

Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global FM market. The report identifies the key trends shaping and driving the global FM market. The report... mehr

Ovarian Disease Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Ovarian Disease Global Clinical Trials Review, H2, 2011' provides data on the Ovarian Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ovarian Disease. It includes an overview of the trial numbers and their recruitment status as per the site of t... mehr

Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global PCOS market. The report identifies the key trends shapin... mehr

Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Polycystic Ovarian Syndrome Therapeutics market. The rep... mehr

Premenstrual Syndrome - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, H2 2011', provides an overview of the Premenstrual Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players... mehr

Cervical Dysplasia - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Cervical Dysplasia - Pipeline Review, H2 2011', provides an overview of the Cervical Dysplasia therapeutic pipeline. This report provides information on the therapeutic development for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in... mehr

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future” which provides insights into the global contraceptives market and market forecasts until 2017. The rep... mehr

Female Sexual Dysfunction - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Female Sexual Dysfunction - Pipeline Review, H2 2011', provides an overview of the Female Sexual Dysfunction therapeutic pipeline. This report provides information on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Menopausal Disorders - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H2 2011', provides an overview of the Menopausal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Menopausal Hot Flashes - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H2 2011', provides an overview of the Menopausal Hot Flashes therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key pla... mehr

Polycystic Ovarian Syndrome Global Clinical Trials Review, H2 2011

Summary

GlobalData's clinical trial report, 'Polycystic Ovarian Syndrome Global Clinical Trials Review, H2, 2011' provides data on the Polycystic Ovarian Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polycystic Ovarian Syndrome. It includes an overview of the trial numbers an... mehr

Uterine Fibroids - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Uterine Fibroids - Pipeline Review, H2 2011', provides an overview of the Uterine Fibroids therapeutic pipeline. This report provides information on the therapeutic development for Uterine Fibroids, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the the... mehr

Uterine Fibroids Global Clinical Trials Review, H2 2011

Summary

GlobalData's clinical trial report, 'Uterine Fibroids Global Clinical Trials Review, H2, 2011' provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment status as per the site o... mehr

Vaginal Atrophy - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Vaginal Atrophy - Pipeline Review, H2 2011', provides an overview of the Vaginal Atrophy therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therape... mehr

Dysmenorrhea - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, H2 2011', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic develop... mehr

Endometriosis - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Endometriosis - Pipeline Review, H2 2011', provides an overview of the Endometriosis therapeutic pipeline. This report provides information on the therapeutic development for Endometriosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic dev... mehr

Infertility - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Infertility - Pipeline Review, H2 2011', provides an overview of the Infertility therapeutic pipeline. This report provides information on the therapeutic development for Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development... mehr

Menopausal Disorders Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Menopausal Disorders Global Clinical Trials Review, H2, 2011' provides data on the Menopausal Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Menopausal Disorders. It includes an overview of the trial numbers and their recruitment status ... mehr

Polycystic Ovarian Syndrome - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Polycystic Ovarian Syndrome - Pipeline Review, H2 2011', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It ... mehr

Women’s Infertility Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Women’s Infertility Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Women’s Infertility Therapeutics market. The report identifies the key trends sh... mehr

Acromegaly and Gigantism Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Acromegaly and Gigantism Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Acromegaly and Gigantism Therapeutics market. The report identifies the key ... mehr

Endometriosis Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, 'Endometriosis Global Clinical Trials Review, H2, 2011' provides data on the Endometriosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endometriosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial con... mehr

Post Menopausal Osteoporosis - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Post Menopausal Osteoporosis - Pipeline Review, H2 2011', provides an overview of the Post Menopausal Osteoporosis therapeutic pipeline. This report provides information on the therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects.... mehr

Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Post Menopausal Osteoporosis Therapeutics market. The report identifie... mehr

Primary Dysmenorrhea - Pipeline Review, H2 2011

Summary

Global Markets Direct’s, 'Primary Dysmenorrhea - Pipeline Review, H2 2011', provides an overview of the Primary Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Primary Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Endometriosis Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Endometriosis Global Clinical Trials Review, Q1, 2011' provides data on the Endometriosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endometriosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial con... mehr

Infertility Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Infertility Global Clinical Trials Review, Q2, 2011' provides data on the Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ... mehr

Polycystic Ovarian Syndrome Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Polycystic Ovarian Syndrome Global Clinical Trials Review, Q2, 2011' provides data on the Polycystic Ovarian Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polycystic Ovarian Syndrome. It includes an overview of the trial numbers a... mehr

Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011' provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial numbe... mehr

Pregnancy Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Pregnancy Global Clinical Trials Review, Q2, 2011' provides data on the Pregnancy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pregnancy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across t... mehr

Uterine Fibroids Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, 'Uterine Fibroids Global Clinical Trials Review, Q2, 2011' provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment status as per the site ... mehr

Premenstrual Syndrome - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, Q2 2011', provides an overview of the Premenstrual Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players... mehr

Post Menopausal Osteoporosis - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Post Menopausal Osteoporosis - Pipeline Review, Q2 2011', provides an overview of the Post Menopausal Osteoporosis therapeutic pipeline. This report provides information on the therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects.... mehr

Primary Dysmenorrhea - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Primary Dysmenorrhea - Pipeline Review, Q2 2011', provides an overview of the Primary Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Primary Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Dysmenorrhea - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, Q1 2011', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic develop... mehr

During 2010, retail sales of emergency contraception grew 13% to reach C$22 million in current value terms. Growth was slower compared to previous years of the review period, which saw significant sales growth as a result of greater access to the product (ie without prescription). Sales nonetheless remained strong throughout 2010 due to the declining teen pregnancy rate and growing preference for career over childbearing amongst Canadia... mehr

Female Sexual Dysfunction - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Female Sexual Dysfunction - Pipeline Review, Q1 2011', provides an overview of the Female Sexual Dysfunction therapeutic pipeline. This report provides information on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also rev... mehr

Menopausal Disorders - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, Q1 2011', provides an overview of the Menopausal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv... mehr

Menopausal Hot Flashes - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, Q1 2011', provides an overview of the Menopausal Hot Flashes therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key pla... mehr

Uterine Fibroids - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Uterine Fibroids - Pipeline Review, Q1 2011', provides an overview of the Uterine Fibroids therapeutic pipeline. This report provides information on the therapeutic development for Uterine Fibroids, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the the... mehr

Vaginal Atrophy - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Vaginal Atrophy - Pipeline Review, Q1 2011', provides an overview of the Vaginal Atrophy therapeutic pipeline. This report provides information on the therapeutic development for Vaginal Atrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therape... mehr

In January 2010, Johnson & Johnson recalled nine lots of its leading brand Simply Sleep. The resulting lack of product availability and consumer scepticism devastated sales for the brand. Consumers responded by choosing private label alternatives, buying other brands and opting for alternative methods to help them sleep. Another possible option, selecting a night-time combination analgesic product, was also limited as Johnson & ... mehr

The emergency contraception market in 2010 enjoyed 9% current value growth, higher than the 7% growth in 2009. Although a scandal concerning the side effects of levonorgestrel including extrauterine pregnancy, which involved Yuting, created some panic at the beginning of 2010, it did not affect the growth trend due to the growing demand for emergency contraception.

Euromonitor International's Emergency Contraception in China ... mehr

Emergency contraception in Estonia stagnated as value sales record EEK7 million in 2010. However, the category survived the decline as the product is often considered a necessity. Women continued to purchase emergency contraception as unwanted pregnancy was a concept completely detached from the economic crisis. Women perceived these products to be essential to avoid pregnancy. Saving at the expense of this product was rather complicat... mehr

Emergency contraception grew by less than 1% in 2010. This was due to the stability of prices in 2010. Volume growth of emergency contraception remained unchanged.

Euromonitor International's Emergency Contraception in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forec... mehr

In August 2009, the FDA approved Watson Pharmaceuticals’ Next Choice emergency contraceptive for OTC sale. The drug is the generic bioequivalent of Plan B, and as Next Choice is priced 10-20% lower than Plan B, its sales took off as soon as it hit the market. In fact, by the end of 2010, sales of Next Choice in its first full year on the market surpassed those of Plan B to make Watson the new category leader.

Euromonitor In... mehr

Endometriosis - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Endometriosis - Pipeline Review, Q1 2011', provides an overview of the Endometriosis therapeutic pipeline. This report provides information on the therapeutic development for Endometriosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic dev... mehr

Hormone Replacement Therapy - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Hormone Replacement Therapy - Pipeline Review, Q1 2011', provides an overview of the Hormone Replacement Therapy therapeutic pipeline. This report provides information on the therapeutic development for Hormone Replacement Therapy, complete with latest updates, and special features on late-stage and discontinued projects. It ... mehr

Infertility - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Infertility - Pipeline Review, Q1 2011', provides an overview of the Infertility therapeutic pipeline. This report provides information on the therapeutic development for Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development... mehr

Polycystic Ovarian Syndrome - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Polycystic Ovarian Syndrome - Pipeline Review, Q1 2011', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It ... mehr

Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market

Summary

GBI Research, the leading business intelligence provider, has released its latest research 'Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market” which provides insight about contraceptive sales and price fo... mehr

Dysmenorrhea - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist’s new report, 'Dysmenorrhea —Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global dysmenorrhea market. The report identifies the key trends shaping and driving the global dysmenorrhea market. The report also provides insight into... mehr

Endometriosis - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, 'Endometriosis - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global endometriosis market. The report identifies the key trends shaping and driving the global endometriosis market. The report a... mehr

Introduction

The urinary incontinence drug market has been displaying strong growth from 2005-09 owing to the uptake of new products driven by large marketing campaigns. Promotional efforts will remain integral to the success of new products entering this competitive market, ideally offering alternative mechanisms of action and potentially improved tolerability.
Features and benefits

* Sales forecasts of marke... mehr

Introduction

The urinary incontinence drug market has been displaying strong growth from 2005-09 owing to the uptake of new products driven by large marketing campaigns. Promotional efforts will remain integral to the success of new products entering this competitive market, ideally offering alternative mechanisms of action and potentially improved tolerability.
Features and benefits

* Sales forecasts of marke... mehr

Women’s Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets

Summary

GBI Research’s report, 'Women's Health Therapeutics Market to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global... mehr

Emergency contraception sales in Bulgaria reached BGN1 million in 2009. This growth was driven by Escapelle, a product of the Hungarian company Richter Gedeon Ltd, launched in 2007. The launch was supported by a massive marketing campaign, which included television, radio, billboard and magazine advertisements and various sponsorships. This not only successfully popularised the product but also created consumer awareness of emergency c... mehr

Emergency contraception recorded value sales of IRR410mn in 2009. It showed current value growth of 55% over the previous year, largely because the product is growing from a small base and retails at a high unit price. It showed good growth as a result of higher demand for this kind of product due to a change in cultural and sexual behaviour of Iranians, particularly the younger generation.

Euromonitor International's Emergen... mehr

In 2009 in value terms the sales of emergency contraception increased by 39% to UAH11 million. Demand for this kind of medicine is not elastic. Moreover, the rising price of condoms (mainly imported) led to a rising number of unplanned pregnancies. Thus the demand for emergency contraception also had a positive rate of growth in 2009.

Euromonitor International's Emergency Contraception Products in Ukraine report offers a comp... mehr

Life Science Analytics', Abnormal Uterine Bleeding Therapy Area Pipeline Report contains detailed information on the abnormal uterine bleeding drug pipeline. This report provides insight into the pipeline status of abnormal uterine bleeding drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Re... mehr

Life Science Analytics', Dysmenorrhea Therapy Area Pipeline Report contains detailed information on the dysmenorrhea drug pipeline. This report provides insight into the pipeline status of dysmenorrhea drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail... mehr

In 2009, value sales of emergency contraception reached DKr11 million, up 3% in current terms on the previous year. Rising consumer awareness of the products’ existence and greater mistrust of the effectiveness of condoms are driving demand. Consumer trust is a key growth driver, and the longer emergency contraception stays successfully on the market, the more women will begin to trust such products and will use them when they think t... mehr

In 2009, sales of emergency contraception increased by 9% in current value terms, to reach EUR10mn. Demand for emergency contraception remained high, but the 2009 growth rate was lower than 2008. The extensive communication campaign undertaken by the French government and different organisations such as INPES (National Institute for Health Prevention and Education) increased public awareness of STDs (sexually transmitted diseases) and A... mehr

In 2009 the Spanish Government decided to allow sales of emergency contraception on an OTC basis. However, the fact the there are 17 different regions which are in charge of implementing this new law has resulted in Catañuña being the only region to actual sell these products OTC. Sales of emergency contraception products thus reached a value of just EUR0.8 million in 2009.

Euromonitor International's Emergency ... mehr

Life Science Analytics', Endometriosis Therapy Area Pipeline Report contains detailed information on the endometriosis drug pipeline. This report provides insight into the pipeline status of endometriosis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real det... mehr

Life Science Analytics', Female Sexual Dysfunction Therapy Area Pipeline Report contains detailed information on the female sexual dysfunction drug pipeline. This report provides insight into the pipeline status of female sexual dysfunction drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Re... mehr

Life Science Analytics', Infertility Therapy Area Pipeline Report contains detailed information on the infertility drug pipeline. This report provides insight into the pipeline status of infertility drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on... mehr

Life Science Analytics', Menopausal Symptoms Therapy Area Pipeline Report contains detailed information on the menopausal symptoms drug pipeline. This report provides insight into the pipeline status of menopausal symptoms drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the ... mehr

Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Polycystic Ovarian Syndrome— Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global polycystic ovarian syndrome market. The report identifies the key trends shaping and driving the global polycys... mehr

Life Science Analytics', Vaginal Infections Therapy Area Pipeline Report contains detailed information on the Vaginal Infections drug pipeline. This report provides insight into the pipeline status of Vaginal Infections drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the use... mehr

Introduction

Drug developers interested on the sexual dysfunction market are searching for the next Viagra. Companies are focusing on premature ejaculation and female hypoactive sexual desire disorder, which are suggested to be as prevalent as erectile dysfunction. As products advance through the pipeline, there are several challenges that will have to be addressed in order to succeed in these markets.

Scope
<... mehr

Introduction

Endometriosis is a common yet poorly understood gynecological disease that affects women of reproductive age. Symptoms include severe chronic pelvic pain and infertility. Endometriosis affects over 17 million women across the seven major markets. Nonetheless, its complex symptomatology contributes to difficult diagnosis and unclear etiology obstructs the discovery of disease modifying approaches.

Scope... mehr

Introduction

In 2008, the six tumor types covered in this report are forecast to account for over 1.2m new cases of cancer. Collectively, the 36 different drugs in Phase III development for the six tumor types are forecast to achieve $7,049m in sales by 2017. This constitutes a significant proportion of the oncology market, thus representing ample commercial opportunities for drug developers.

Scope

*Exam... mehr

Introduction

In 2008, the six tumor types covered in this report are forecast to account for over 1.2m new cases of cancer. Collectively, the 36 different drugs in Phase III development for the six tumor types are forecast to achieve $7,049m in sales by 2017. This constitutes a significant proportion of the oncology market, thus representing ample commercial opportunities for drug developers.

Scope

*Exam... mehr

Introduction

The treatment of menopausal symptoms is a common clinical challenge, with vasomotor symptoms affecting an estimated 75% of women aged over 50 years. Hormone replacement therapy (HRT) has formed the mainstay of treatment for almost 60 years and is highly efficacious. However, concerns surrounding the safety of HRT have led to an increase in demand for non-hormonal alternatives.

Scope

Overview... mehr

Life Science Analytics', 'Kidneys and Genito-Urinary System Urinary Incontinence ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real... mehr

Life Science Analytics', 'Metabolic Endocrinology Hypogonadism ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pi... mehr

Life Science Analytics', 'Women's Health Contraception ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines,... mehr

Life Science Analytics', 'Women's Health Dysmenorrhea ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, ... mehr

Life Science Analytics', 'Women's Health Endometriosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines,... mehr

Life Science Analytics', 'Women's Health Female Sexual Dysfunction ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on dru... mehr

Life Science Analytics', 'Women's Health Infertility ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, b... mehr

Life Science Analytics', 'Women's Health Labor and Delivery ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipel... mehr

Life Science Analytics', 'Women's Health Menopausal Symptoms ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipe... mehr

Life Science Analytics', 'Women's Health Postmenopausal Osteoporosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on d... mehr

Life Science Analytics', 'Women's Health Vaginal Infections ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipel... mehr